Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Psychiatry
•
Diabetes
•
General Outpatient Psychiatry
•
Major Depressive Disorder
Do you recommend avoiding the use of GLP-1 agonists in patients with a history of suicidal thoughts, given recent evidence showing an association with increased risks of psychiatric disorders, including depression and suicidal behavior?
Kornelius E, et al., PMID 39424950
Related Questions
Would you be comfortable using isotretinoin in a female teenage patient who has a history of depression that is now stable but with a prior suicide attempt two years ago?
Would you consider over-the-counter dextromethorphan (low dose, slow titration) as augmentation in MDD?
How do you counsel/approach antidepressant use in patients planning to utilize or self-administer psychedelics for chronic PTSD or depression?
How do you assess and adjust treatment in patients who develops hypothyroidism after being on lithium for several years?
How do you evaluate patients who report medications frequently "stop working" after long periods of stability?
How do you approach treatment-resistant depression and anxiety related to menopause refractory to SSRI/SNRIs and hormone replacement therapy?
How do you define treatment-resistant depression in your practice?
How do you handle elevated blood calcium levels from lithium?
How do you decide when to initiate medical workup (e.g., thyroid, B12, infection) in a geriatric patient experiencing new onset or worsening low mood?
What strategies have you found helpful to manage SSRI associated night sweats?
